Efficacy and safety of FDA-approved IDH inhibitors in the treatment of IDH mutated acute myeloid leukemia: a systematic review and meta-analysis

OBJECTIVE: To systematically evaluate the efficacy and safety of FDA-approved isocitrate dehydrogenase (IDH) inhibitors in the treatment of IDH-mutated acute myeloid leukemia (AML). METHODS: We used R software to conduct a meta-analysis of prospective clinical trials of IDH inhibitors in the treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiu, Xing, Hongyun, Xie, Xiaolu, Kou, Liqiu, Li, Jun, Li, Yaling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334617/
https://www.ncbi.nlm.nih.gov/pubmed/37434249
http://dx.doi.org/10.1186/s13148-023-01529-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334617/
https://www.ncbi.nlm.nih.gov/pubmed/37434249
http://dx.doi.org/10.1186/s13148-023-01529-2

Ejemplares similares